Aquilus Pharmaceuticals
Phase 1Aquilus Pharmaceuticals is dedicated to developing a first-in-class medication for neurodegenerative diseases, with a primary focus on Amyotrophic Lateral Sclerosis (ALS). Our mission is to make a meaningful impact on patients' lives by advancing therapeutics in this challenging field
Founded
2018
Focus
Small Molecules
About
Aquilus Pharmaceuticals is dedicated to developing a first-in-class medication for neurodegenerative diseases, with a primary focus on Amyotrophic Lateral Sclerosis (ALS). Our mission is to make a meaningful impact on patients' lives by advancing therapeutics in this challenging field
Funding History
7Total raised: $3.6M
Grant$458KNINDSSep 7, 2019
Grant$1.4MNIDCRJul 27, 2016
Grant$287KNCISep 23, 2015
Grant$556KNIDCRJul 23, 2015
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile